Skip to main content
Español

Amgen Inc. Company Information

www.drugs.com/manufacturer/amgen-inc-18.html

Amgen Latest news Associated drugs Amgen Inc. 1 Amgen Center Drive Thousand Oaks, CA 91320-1799 Phone: (805) 447-1000 Website: Careers: careers.amgen.com Patient Assistance Program: www.amgen.com / responsibility... Latest news FDA Approves Lumakras (sotorasib) in Combination with Vectibix...

AMGEN 30 Pill Green Oval 10mm - Pill Identifier

Pill Identification (Drugs.com)

AMGEN 30 Pill - green oval, 10mm Pill with imprint AMGEN 30 is Green, Oval and has been identified as Sensipar 30 mg. It is supplied by Amgen USA. Sensipar is used in the treatment of Primary Hyperparathyroidism ; Secondary Hyperparathyroidism ; Hypercalcemia of Malignancy and belongs to the drug...

Amgen results from the Pill Identifier

  • Pill AMGEN 60 Green Oval is Sensipar
  • Pill AMGEN 90 Green Oval is Sensipar
  • Pill AMGEN 30 Green Oval is Sensipar

AMGEN 60 Pill Green Oval 12mm - Pill Identifier

Pill Identification (Drugs.com)

AMGEN 60 Pill - green oval, 12mm Pill with imprint AMGEN 60 is Green, Oval and has been identified as Sensipar 60 mg. It is supplied by Amgen USA. Sensipar is used in the treatment of Primary Hyperparathyroidism ; Secondary Hyperparathyroidism ; Hypercalcemia of Malignancy and belongs to the drug...

AMGEN 90 Pill Green Oval 14mm - Pill Identifier

Pill Identification (Drugs.com)

AMGEN 90 Pill - green oval, 14mm Pill with imprint AMGEN 90 is Green, Oval and has been identified as Sensipar 90 mg. It is supplied by Amgen USA. Sensipar is used in the treatment of Primary Hyperparathyroidism ; Secondary Hyperparathyroidism ; Hypercalcemia of Malignancy and belongs to the drug...

Clinical Trials: Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis MedNews

Clinical Trial Results (FDA)

Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis THOUSAND OAKS, Calif., and TOKYO , March 8, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new...

See also:

Prolia

Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...

Reviews & ratings
2.9 / 10
374 Reviews
View more

Decadron

Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...

Reviews & ratings
3.9 / 10
29 Reviews
View more
Featured

Breztri Aerosphere

Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler that may be used ...

Reviews & ratings
7.0 / 10
121 Reviews
View more

Reclast

Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...

Reviews & ratings
5.1 / 10
275 Reviews
View more

Dexamethasone Intensol

Dexamethasone Intensol is used for addison's disease, adrenal insufficiency, adrenocortical ...

Reviews & ratings
4 Reviews
View more

Zometa

Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...

Reviews & ratings
4.8 / 10
44 Reviews
View more

Deltasone

Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...

Reviews & ratings
6.6 / 10
8 Reviews
View more

Xgeva

Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is ...

Reviews & ratings
6.1 / 10
9 Reviews
View more

Rayos

Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...

Reviews & ratings
3 Reviews
View more

Aclasta

Aclasta (zoledronic acid) inhibits the release of calcium from bones and is used to treat Paget's ...

Reviews & ratings
4.3 / 10
29 Reviews
View more

Clinical Trials: Amgen Announces Robust Weight Loss With MariTide in People Living With Obesity or Overweight at 52 Weeks in a Phase 2 Study MedNews

Clinical Trial Results (FDA)

Amgen Announces Robust Weight Loss With MariTide in People Living With Obesity or Overweight at 52 Weeks in a Phase 2 Study THOUSAND OAKS, Calif. , Nov. 26, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide...

Repatha: Uses, Dosage, Side Effects & Warnings Consumer Information

Consumer Information (Drugs.com)

...healthcare provider if you become pregnant while taking Repatha. If you or your child are pregnant during Repatha treatment, you are encouraged to call Amgen at 1-800-772-6436 (1-800-77-AMGEN) or visit their adverse event and product complaint reporting page to share information about the health of you and...

Aimovig: Uses, Dosage, and Side Effects Consumer Information

Consumer Information (Drugs.com)

...17, 2018, for Amgen Inc. There is no generic available. Aimovig side effects Common Aimovig side effects The most common Aimovig side effects include: Injection site reactions including pain , redness, or swelling at the injection site (6%) constipation (1%) cramps , muscle spasms (<1%). These...

Avacopan: Uses, Dosage, Side Effects, Warnings Consumer Information

Consumer Information (Drugs.com)

ChemoCentryx, a biopharmaceutical company specializing in oral medications for autoimmune diseases, inflammatory disorders, and cancers. ChemoCentryx was acquired by Amgen, a leading independent biotechnology company, on October 20, 2022. Avacopan FDA approval  Avacopan FDA approval was received on...

Tavneos: Uses, Dosage, Side Effects & Warnings Consumer Information

Consumer Information (Drugs.com)

...(avacopan) available. Tavneos was developed by ChemoCentryx, a biopharmaceutical company specializing in oral medications for autoimmune diseases, inflammatory disorders, and cancers. ChemoCentryx was acquired by Amgen, a leading independent biotechnology company, on October 20, 2022. Tavneos FDA approval...